Requisite Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Requisite Capital Management's LLY Position: Q2 2026 in Review
Requisite Capital Management increased its Eli Lilly (LLY) stake by 2.9% in Q2 2026, buying an estimated $7.15K and bringing the position to 245 shares worth $294K. The position accounts for 0.05% of the portfolio, ranked #95.
Requisite Capital Management first reported a position in LLY in Q3 2023 and has held it in 10 quarters since. The position peaked at $1.01M in Q1 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Requisite Capital Management held 245 shares of Eli Lilly worth $294K as of Q2 2026.
- Requisite Capital Management bought 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
- Eli Lilly made up 0.05% of Requisite Capital Management's portfolio in Q2 2026, its #95 holding.
- Requisite Capital Management first reported a position in Eli Lilly in Q3 2023 and has held it in 10 quarters since.
- Requisite Capital Management's Eli Lilly position peaked at $1.01M in Q1 2024.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Requisite Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.